Raymond James Downgrades Meridian Biosciences (VIVO) to Market Perform
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.87 +6.10%
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Raymond James downgraded Meridian Biosciences (NASDAQ: VIVO) from Strong Buy to Market Perform.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $18.02 yesterday.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $18.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Wedbush Downgrades Globant S.A. (GLOB) to Neutral on balanced risk/reward
- JPMorgan Downgrades KinderCare Learning Companies (KLC) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
